Unifarma SA
5.5 FTEUnifarma reported total assets of €3.56m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026), with 5.5 full-time equivalents.
The score of Unifarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -8 % Total assets -7 % Headcount (avg FTE) -31 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Unifarma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 06 Jun 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Unifarma's financial analysis
- Solvency92.8%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Unifarma
Unifarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0422.674.530
- VAT number
- BE0422674530
- Peppol
- Registered · 0208:0422674530 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Apr 1982
- Registered office
- 8500 Kortrijk
- Size
- Micro · 5.5 FTE
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Unifarma (SA) has been based in Kortrijk since 1982, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 122,718 € and equity of €3.30m; its revenue is not published. With 5.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 92.8%, above the median of its sector (44.0%).
Companies similar to Unifarma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Crossver Retail sale of pharmaceutical products Wielsbeke · balance sheet €3.78m
- Apotheek Devriese Retail sale of pharmaceutical products Torhout · balance sheet €3.84m
- Pharmaceutica Retail sale of pharmaceutical products Lier · balance sheet €3.84m
- E.V.N. Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet €3.28m
- Mouscron Pharma Retail sale of pharmaceutical products Mouscron · balance sheet €3.25m
- GDK Farma Retail sale of pharmaceutical products Grimbergen · balance sheet €3.07m
- Xpharma Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet €3.07m
Frequently asked questions about Unifarma
What is the revenue of Unifarma?
Unifarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Unifarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0422674530 for Unifarma, if the company is VAT-registered. Its company number (CBE) is 0422.674.530.
Where is the registered office of Unifarma?
According to the CBE register, the registered office of Unifarma is in 8500 Kortrijk.
What is the equity of Unifarma?
At the close of the 2025 financial year, the equity of Unifarma amounts to 3,303,143 €, a solvency of 92.8% of total assets.
How many people work at Unifarma?
5.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Unifarma?
The register lists 8 active mandates at Unifarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Unifarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →